PRT versus IMRT toxicity in Medicare beneficiaries with prostate cancer
Monday, December 17, 2012 - 18:00
in Health & Medicine
There is no difference between proton radiotherapy and intensity-modulated radiotherapy when comparing the toxicity among Medicare beneficiary patients with prostate cancer at 12 months post-treatment, according to a new study.